Sandra Carson's most recent trade in Agile Therapeutics Inc was a trade of 1,065 Employee Stock Option (Right to Buy) done . Disclosure was reported to the exchange on June 8, 2023.
Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
---|---|---|---|---|---|---|---|---|---|---|
Agile Therapeutics Inc | Sandra Carson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Jun 2023 | 1,065 | 1,065 | - | - | Employee Stock Option (Right to Buy) | |
Agile Therapeutics Inc | Sandra Carson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Jun 2023 | 935 | 974 (0%) | 0% | 0 | Common Stock | |
Agile Therapeutics Inc | Sandra Carson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Jun 2022 | 807 | 807 | - | - | Employee Stock Option (Right to Buy) | |
Agile Therapeutics Inc | Sandra Carson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Jun 2022 | 670 | 1,952 (0%) | 0% | 0 | Common Stock | |
Agile Therapeutics Inc | Sandra Carson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Jun 2021 | 29,905 | 29,905 | - | - | Employee Stock Option (Right to Buy) | |
Agile Therapeutics Inc | Sandra Carson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Jun 2021 | 24,510 | 51,296 (0%) | 0% | 0 | Common Stock | |
Agile Therapeutics Inc | Sandra Carson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Jun 2020 | 45,212 | 45,212 | - | - | Employee Stock Option (Right to Buy) | |
Agile Therapeutics Inc | Sandra Carson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Jun 2020 | 26,786 | 26,786 (0%) | 0% | 0 | Common Stock |